耳鼻咽喉科新发和再发传染病
Emerging and re-emerging infectious disease in otorhinolaryngology.
作者信息
Scasso F, Ferrari G, DE Vincentiis G C, Arosio A, Bottero S, Carretti M, Ciardo A, Cocuzza S, Colombo A, Conti B, Cordone A, DE Ciccio M, Delehaye E, Della Vecchia L, DE Macina I, Dentone C, DI Mauro P, Dorati R, Fazio R, Ferrari A, Ferrea G, Giannantonio S, Genta I, Giuliani M, Lucidi D, Maiolino L, Marini G, Marsella P, Meucci D, Modena T, Montemurri B, Odone A, Palma S, Panatta M L, Piemonte M, Pisani P, Pisani S, Prioglio L, Scorpecci A, Scotto DI Santillo L, Serra A, Signorelli C, Sitzia E, Tropiano M L, Trozzi M, Tucci F M, Vezzosi L, Viaggi B
机构信息
SOC Otorinolaringoiatria, ASL 3 Genovese, Ospedale P.A. Micone, Genova, Italy.
SOC Otorinolaringoiatria, ASL 5 Genovese, Ospedale P.A. Levante Ligure, La Spezia, Italy.
出版信息
Acta Otorhinolaryngol Ital. 2018 Apr;38(SUPPL. 1):S1-S106. doi: 10.14639/0392-100X-suppl.1-38-2018.
Emerging and re-emerging infectious disease in otorhinolaryngology (ENT) are an area of growing epidemiological and clinical interest. The aim of this section is to comprehensively report on the epidemiology of key infectious disease in otorhinolaryngology, reporting on their burden at the national and international level, expanding of the need of promoting and implementing preventive interventions, and the rationale of applying evidence-based, effective and cost- effective diagnostic, curative and preventive approaches. In particular, we focus on i) ENT viral infections (HIV, Epstein-Barr virus, Human Papilloma virus), retrieving the available evidence on their oncogenic potential; ii) typical and atypical mycobacteria infections; iii) non-specific granulomatous lymphadenopathy; iv) emerging paediatric ENT infectious diseases and the prevention of their complications; v) the growing burden of antimicrobial resistance in ENT and the strategies for its control in different clinical settings. We conclude by outlining knowledge gaps and action needed in ENT infectious diseases research and clinical practice and we make references to economic analysis in the field of ENT infectious diseases prevention and care.
耳鼻咽喉科（ENT）中新发和再发传染病是流行病学和临床领域日益受到关注的一个方面。本节的目的是全面报告耳鼻咽喉科主要传染病的流行病学情况，报告其在国家和国际层面的负担，阐述促进和实施预防干预措施的必要性，以及应用循证、有效且具有成本效益的诊断、治疗和预防方法的基本原理。具体而言，我们重点关注以下方面：i）耳鼻咽喉科病毒感染（HIV、EB病毒、人乳头瘤病毒），收集有关其致癌潜力的现有证据；ii）典型和非典型分枝杆菌感染；iii）非特异性肉芽肿性淋巴结病；iv）新发儿童耳鼻咽喉科传染病及其并发症的预防；v）耳鼻咽喉科抗菌药物耐药性日益增加的负担以及在不同临床环境中控制耐药性的策略。我们通过概述耳鼻咽喉科传染病研究和临床实践中存在的知识空白和所需行动来结束本文，并提及耳鼻咽喉科传染病预防和护理领域的经济分析。
Zotero 插件